Multi-targeting Andrographolide and its Natural Analogs as Potential Therapeutic Agents
V Kishore, Nagendra Sastry Yarla1, Anupam Bishayee
1Department of Biochemistry, Institute of Science, GITAM University, Visakhapatnam, Andhra Pradesh, India.
Current Topics in Medicinal Chemistry
|October 5, 2016
Summary
Andrographis paniculata, containing andrographolide, offers therapeutic benefits including anti-inflammatory and hepatoprotective effects. Further research explores its diverse pharmacological activities and mechanisms for disease prevention.
Area of Science:
- Phytochemistry
- Pharmacology
- Traditional Medicine
Background:
- Andrographis paniculata (A. paniculata) is a medicinal herb utilized in traditional Indian and Chinese medicine.
- Its therapeutic properties are primarily attributed to the compound andrographolide, a diterpene lactone.
- Andrographolide and its analogs exhibit a wide range of biological activities.
Purpose of the Study:
- To provide a comprehensive overview of the therapeutic and pharmacological activities of andrographolide and its derivatives.
- To highlight the potential of A. paniculata compounds in disease prevention.
- To exemplify the underlying mechanisms responsible for these biological actions.
Main Methods:
- Literature review of scientific studies on Andrographis paniculata and andrographolide.
- Analysis of reported biological activities and pharmacological effects.
- Examination of research investigating the mechanisms of action.
Main Results:
- Andrographolide and related terpenoids possess significant anti-inflammatory, anti-tumour, anti-hyperglycaemic, anti-fertility, antiviral, cardioprotective, and hepatoprotective properties.
- Structural similarities among these compounds correlate with diverse pharmacological activities.
- Ongoing research aims to elucidate the specific molecular pathways involved.
Conclusions:
- Andrographolide and its derivatives from A. paniculata represent a promising source for therapeutic agents.
- The diverse pharmacological profile supports their use in disease prevention and treatment.
- Further mechanistic studies are crucial for drug development and validation.
Related Concept Videos
Targets for Drug Action: Overview
11.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.0K
Principles of Drug Action
9.2K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
61
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.7K
1.7K
Drug-Receptor Interaction: Agonist
4.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.5K


